Changes in prenatal cannabis-related diagnosed disorders after the Cannabis Act and the COVID-19 pandemic in Quebec, Canada
- PMID: 38898560
- DOI: 10.1111/add.16564
Changes in prenatal cannabis-related diagnosed disorders after the Cannabis Act and the COVID-19 pandemic in Quebec, Canada
Abstract
Background and aims: Public health concerns regarding pregnant women's health after the enactment of the Cannabis Act in Canada (CAC) (a law that allowed non-medical cannabis use), and the potential impact of the COVID-19 pandemic, call for a contemporary assessment of these two events. Our study measured associations between the CAC, the COVID-19 pandemic and the monthly prevalence rates of cannabis-, all drug- and alcohol-related diagnosed disorders among pregnant women in the province of Quebec.
Design, setting and participants: This was a quasi-experimental design applying an interrupted time-series methodology in the province of Quebec, Canada. The participants were pregnant women aged 15-49 years, between January 2010 and July 2022.
Measurements: Administrative health data from the Québec Integrated Chronic Disease Surveillance System were used to classify pregnant women according to cannabis-, all drug (excluding cannabis)- and alcohol-related disorders. The CAC (October 2018) and the COVID-19 pandemic (April 2020) were evaluated as (1) slope changes and (2) level changes. Cannabis-, all drug (excluding cannabis)- and alcohol-related disorders were measured by total monthly age-standardized monthly prevalence rate of each disorder for pregnant women aged 15-49 years.
Findings: Before the CAC, the prevalence rate of cannabis-related diagnosed disorders significantly increased each month by 0.5% [95% confidence interval (CI) = 0.3-0.6] in the pregnant population. After the CAC, there were significant increases of 24% (95% CI = 1-53) of cannabis-related diagnosed disorders. No significant changes were observed for all drug (excluding cannabis)- and alcohol-related diagnosed disorders associated with the CAC. A non-significant decrease of 20% (95% CI = -38 to 3) was observed during the COVID-19 pandemic in alcohol-related disorders.
Conclusions: The monthly incidence rates of diagnosed cannabis-related disorders in pregnant women in Quebec increased significantly following the enactment of the Cannabis Act in Canada. Diagnoses of all drug (excluding cannabis)- and alcohol-related disorders remained relatively stable.
Keywords: COVID‐19; Cannabis; Cannabis Act; Quebec; prenatal cannabis use disorder; time‐series.
© 2024 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.
Similar articles
-
Changes in the incidence of cannabis-related disorders after the Cannabis Act and the COVID-19 pandemic in Québec, Canada.Int J Drug Policy. 2024 Jul;129:104484. doi: 10.1016/j.drugpo.2024.104484. Epub 2024 Jun 13. Int J Drug Policy. 2024. PMID: 38870546
-
The association between recreational cannabis legalization, commercialization and cannabis-attributable emergency department visits in Ontario, Canada: an interrupted time-series analysis.Addiction. 2022 Jul;117(7):1952-1960. doi: 10.1111/add.15834. Epub 2022 Feb 17. Addiction. 2022. PMID: 35170149
-
Assessing the impact of the COVID-19 pandemic on the mental health-related hospitalization rate of youth in Canada: an interrupted time series analysis.Health Promot Chronic Dis Prev Can. 2024 Oct;44(10):417-430. doi: 10.24095/hpcdp.44.9.02. Health Promot Chronic Dis Prev Can. 2024. PMID: 39388293 Free PMC article.
-
[Consequences of tobacco, cocaine and cannabis consumption during pregnancy on the pregnancy itself, on the newborn and on child development: A review].Encephale. 2015 Jun;41 Suppl 1:S13-20. doi: 10.1016/j.encep.2014.08.012. Epub 2014 Oct 28. Encephale. 2015. PMID: 25439854 Review. French.
-
[Domestic violence among Quebec women during the health crisis: Trends and risk factors].Soins. 2024 Jul-Aug;69(887):15-19. doi: 10.1016/j.soin.2024.05.007. Epub 2024 Jun 26. Soins. 2024. PMID: 39019510 Review. French.
References
REFERENCES
-
- Bahji A, Kaur S, Devoe D, Patten S. Trends in Canadian cannabis consumption over time: a two‐step meta‐analysis of Canadian household survey data. Can J Addict. 2022;13(3):6–13.
-
- Imtiaz S, Nigatu YT, Ali F, Douglas L, Hamilton HA, Rehm J, et al. Cannabis legalization and cannabis use, daily cannabis use and cannabis‐related problems among adults in Ontario, Canada (2001–2019). Drug Alcohol Depend. 2023;244:109765.
-
- Meinhofer A, Witman A, Murphy SM, Bao Y. Medical marijuana laws are associated with increases in substance use treatment admissions by pregnant women. Addiction. 2019;114:1593–1601.
-
- Smith WT. Women with a substance use disorder: treatment completion, pregnancy, and compulsory treatment. J Subst Abuse Treat. 2020;116:108045.
-
- Windle SB, Socha P, Nazif‐Munoz JI, Harper S, Nandi A. The impact of cannabis decriminalization and legalization on road safety outcomes: a systematic review. Am J Prev Med. 2022;63:1037–1052.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous